Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IRMD | US
-2.17
-2.27%
Healthcare
Medical Devices
30/06/2024
07/04/2026
93.49
95.66
96.00
92.94
IRADIMED CORPORATION develops manufactures markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles wireless remote displays/controls side car pump modules dose error reduction systems and SpO2 monitoring with sensors and accessories. It serves hospitals acute care facilities and outpatient imaging centers. The company sells its products through direct field sales representatives regional sales directors clinical support representatives and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs Florida.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Smallcap (300M - 2B USD)
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
26.5%1 month
25.4%3 months
32.6%6 months
33.1%35.49
30.12
8.20
0.00
0.00
27.17
8.70
4.46
22.26M
1.18B
1.18B
1.16
31.39
15.20
11.20
25.08
1.39
0.93
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
10.33
Range1M
10.71
Range3M
14.96
Rel. volume
1.38
Price X volume
10.75M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | PLSE | Medical Instruments & Supplies | 19.96 | 1.22B | -12.99% | n/a | 32.05% |
| PROCEPT BioRobotics Corporation Common Stock | PRCT | Medical Devices | 23.19 | 1.20B | -2.48% | n/a | 32.18% |
| Move Inc | MOVE | Medical Devices | 12.13 | 1.20B | 59.31% | n/a | 0.85% |
| Tandem Diabetes Care Inc | TNDM | Medical Devices | 18.28 | 1.20B | -4.64% | n/a | 204.00% |
| CONMED Corporation | CNMD | Medical Devices | 34.54 | 1.06B | 1.35% | 21.14 | 109.53% |
| AZTA | AZTA | Medical Instruments & Supplies | 21.71 | 1.06B | -3.90% | n/a | 3.59% |
| INMODE LTD. | INMD | Medical Devices | 13.65 | 1.04B | -0.44% | 10.28 | 0.00% |
| STAAR Surgical Company | STAA | Medical Instruments & Supplies | 21.09 | 1.04B | 0.62% | 94.12 | 8.87% |
| BioLife Solutions Inc | BLFS | Medical Instruments & Supplies | 19.13 | 882.62M | -0.73% | n/a | 11.19% |
| Butterfly Network Inc. | BFLY | Medical Devices | 4.05 | 860.92M | -1.94% | n/a | 12.34% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Marcus & Millichap Inc | MMI | Real Estate Services | 26.28 | 1.02B | 1.23% | n/a | 14.11% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.03 | 730.97M | 0.60% | 11.62 | 116.21% |
| Comstock Mining Inc | LODE | Real Estate Services | 3.27 | 675.70M | -5.49% | 6.38 | 14.37% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 5.17 | 597.53M | -2.08% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 21.72 | 564.80M | -0.23% | 13.28 | 2.28% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 2.45 | 484.50M | -3.16% | n/a | 0.00% |
| FRP Holdings Inc | FRPH | Real Estate Services | 22.13 | 421.14M | -0.23% | 75.50 | 42.65% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 2.84 | 272.07M | -1.73% | n/a | 174.23% |
| The RMR Group Inc | RMR | Real Estate Services | 15.81 | 264.42M | -0.50% | 16.64 | 14.14% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 18.85 | 185.90M | -2.43% | 14.10 | 17.12% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 27.17 | 46.09 | Cheaper |
| Ent. to Revenue | 8.70 | 14.34 | Cheaper |
| PE Ratio | 35.49 | 30.41 | Par |
| Price to Book | 8.20 | 6.21 | Expensive |
| Dividend Yield | 1.16 | 1.78 | Poor |
| Std. Deviation (3M) | 32.63 | 64.12 | Lower Risk |
| Debt to Equity | 0.00 | -145.53 | Expensive |
| Debt to Assets | 0.00 | 0.35 | Cheaper |
| Market Cap | 1.18B | 9.70B | Emerging |